Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Hospira – Recall of bleomycin injection
December 22, 2023 - Hospira, a Pfizer company, announced a consumer level recall of one lot of bleomycin for injection, due to a confirmed customer report for the presence of glass particulate within a single vial.
